Patents Assigned to JUMBO DRUG BANK CO., LTD.
  • Substituted pyrazlo[3,4-c]pyridines as selective BTK kinase inhibitors
    Patent number: 11739090
    Abstract: Disclosed are a class of BTK kinase inhibitor compounds with a high activity and a high selectivity and the use thereof in the preparation of a drug for treating BTK target-related diseases. Specifically, disclosed are a compound shown as formula (I), and an isomer and a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: August 29, 2023
    Assignee: JUMBO DRUG BANK CO., LTD.
    Inventors: Chunli Shen, XiaWei Wei, Chengde Wu, Guoping Hu, Ning Jiang, Wei Zheng, Jian Li, Shuhui Chen